As a result of extreme reimbursement cuts in the US State of Washington Medicaid program, drug store chain Walgreens says it will withdraw 44 of its pharmacies from the state's Medicaid program as of May 1. These represent more than 60% of the company's total Medicaid business in the state and are found in both large and small communities. Walgreens operates 111 pharmacies throughout Washington.
Under a new Medicaid reimbursement rule set to take effect on April 1, the State of Washington will significantly reduce the price it will pay for brand name medications, severely impacting the economic viability of doing business in Washington.
Kermit Crawford, Walgreens senior vice president of pharmacy, said: "we have made the decision to stop filling Medicaid prescriptions in these pharmacies after long and careful deliberations. Walgreens is the market leader in Washington and provides cost-effective pharmacy service across the state. We have thousands of loyal patients who appreciate and trust our pharmacists, and we are absolutely committed to patient care."
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze